Truxima Hits 20% Share For Teva

Rheumatoid Arthritis Indication Helps Rituximab Biosimilar Gain Ground In US

 
• By David Wallace
  
Cake slice
Teva’s rituximab biosimilar captures a fifth of the US market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products